BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, Cox JL, Dorian P, Gladstone DJ, Healey JS, Khairy P, Leblanc K, McMurtry MS, Mitchell LB, Nair GM, Nattel S, Parkash R, Pilote L, Sandhu RK, Sarrazin JF, Sharma M, Skanes AC, Talajic M, Tsang TSM, Verma A, Verma S, Whitlock R, Wyse DG, Macle L; Members of the Secondary Panel. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Can J Cardiol 2020;36:1847-948. [PMID: 33191198 DOI: 10.1016/j.cjca.2020.09.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Um KJ, McIntyre WF, Mendoza PA, Ibrahim O, Nguyen ST, Lin SH, Duceppe E, Rochwerg B, Healey JS, Koziarz A, Lengyel AP, Bhatnagar A, Amit G, Chu VA, Whitlock RP, Belley-Côté EP. Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis. Europace 2022:euac063. [PMID: 35654763 DOI: 10.1093/europace/euac063] [Reference Citation Analysis]
2 Linton J, Eagles D, Green MS, Alchi S, Nemnom M, Stiell IG. Diagnosis and management of wide complex tachycardia in the emergency department. Can J Emerg Med. [DOI: 10.1007/s43678-021-00243-3] [Reference Citation Analysis]
3 Das S, Deb A, Pal T. Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas. Med Princ Pract 2021;30:412-21. [PMID: 33849034 DOI: 10.1159/000516471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Stiell IG, de Wit K, Scheuermeyer FX, Vadeboncoeur A, Angaran P, Eagles D, Graham ID, Atzema CL, Archambault PM, Tebbenham T, McRae AD, Cheung WJ, Parkash R, Deyell MW, Baril G, Mann R, Sahsi R, Upadhye S, Brown E, Brinkhurst J, Chabot C, Skanes A. 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist. CJEM 2021;23:604-10. [PMID: 34383280 DOI: 10.1007/s43678-021-00167-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Gencher JA, Hawkins NM, Deyell MW, Andrade JG. Management of Atrial Tachyarrhythmias in Heart Failure—an Interventionalist’s Point of View. Curr Heart Fail Rep. [DOI: 10.1007/s11897-022-00543-4] [Reference Citation Analysis]
6 Motazedian P, Coutinho T, Ramirez FD. Female representation in clinical studies informing atrial fibrillation guidelines: have we built a house of cards? Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.01.023] [Reference Citation Analysis]
7 Cappato R. Implementation of Guidelines on Atrial Fibrillation Management in the Global Arena: So Many Actors on Stage! Eur J Intern Med 2021;86:22-4. [PMID: 33838989 DOI: 10.1016/j.ejim.2021.03.013] [Reference Citation Analysis]
8 Gerull B. At Risk or Not at Risk-The Contribution of Clinical and Genetic Risk Factors to Atrial Fibrillation. Can J Cardiol 2021;37:816-8. [PMID: 33549823 DOI: 10.1016/j.cjca.2021.01.025] [Reference Citation Analysis]
9 Mao YJ, Feng WY, Huang QY, Yu FL, Chen JX, Wang H. Meta-analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation. Clin Cardiol 2021. [PMID: 34327708 DOI: 10.1002/clc.23695] [Reference Citation Analysis]
10 Aguilar M, Heijman J, Dobrev D, Nattel S. One Ring to Rule Them All: Continuous Monitoring of Patients With Secondary Atrial Fibrillation Points to a Unifying Underlying Mechanism. Can J Cardiol 2021;37:686-9. [PMID: 33493661 DOI: 10.1016/j.cjca.2021.01.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rahme E, Godin R, Nedjar H, Dasgupta K, Tagalakis V. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Thromb Res 2021;203:121-30. [PMID: 34000493 DOI: 10.1016/j.thromres.2021.05.005] [Reference Citation Analysis]
12 Boivin-proulx L, Potter BJ, Dorais M, Perreault S. Comparative Effectiveness and Safety of DOAC Versus Warfarin among Obese Patients with Atrial Fibrillation. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.01.002] [Reference Citation Analysis]
13 Alsagaff MY, Susilo H, Pramudia C, Juzar DA, Amadis MR, Julario R, Raharjo SB, Dharmadjati BB, Lusida TTE, Azmi Y, Doevendans PA; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, Indonesia, Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, Netherlands. Rapid Atrial Fibrillation in the Emergency Department. Heart International 2022;16:12. [DOI: 10.17925/hi.2022.16.1.12] [Reference Citation Analysis]
14 Beaulieu MC, Boivin-Proulx LA, Matteau A, Mansour S, Gobeil JF, Potter BJ. Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake. CJC Open 2021;3:1025-32. [PMID: 34505042 DOI: 10.1016/j.cjco.2021.04.002] [Reference Citation Analysis]
15 Reed JL, Blanchard CM, Parkash R. An Evaluation of Device-Measured Physical Activity Levels of Patients With Nonpermanent Atrial Fibrillation. J Cardiopulm Rehabil Prev 2021;41:440-2. [PMID: 34727565 DOI: 10.1097/HCR.0000000000000640] [Reference Citation Analysis]
16 Yogasundaram H, Dover DC, Hawkins NM, McAlister FA, Goodman SG, Ezekowitz J, Kaul P, Sandhu RK. Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings. J Am Heart Assoc 2022;:e024868. [PMID: 35876419 DOI: 10.1161/JAHA.121.024868] [Reference Citation Analysis]
17 Hu W, Cai H, Zhang J. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data. Eur J Clin Pharmacol 2022. [PMID: 35296907 DOI: 10.1007/s00228-022-03300-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Carlin S, Bond A, Gross P, Bell A, Douketis J, Geerts W, Galanaud JP. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res 2021;202:176-81. [PMID: 33872825 DOI: 10.1016/j.thromres.2021.04.004] [Reference Citation Analysis]
19 Adam L. Potential benefits of pharmacist intervention in the detection and therapy of atrial fibrillation. Can Pharm J (Ott) 2021;154:240-1. [PMID: 34345315 DOI: 10.1177/17151635211019963] [Reference Citation Analysis]
20 Noubiap JJ, Agbaedeng TA, Ndoadoumgue AL, Nyaga UF, Kengne AP. Atrial thrombus detection on transoesophageal echocardiography in patients with atrial fibrillation undergoing cardioversion or catheter ablation: A pooled analysis of rates and predictors. J Cardiovasc Electrophysiol 2021;32:2179-88. [PMID: 33969568 DOI: 10.1111/jce.15082] [Reference Citation Analysis]
21 Aguilar M, Rose RA, Takawale A, Nattel S, Reilly S. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation. Cardiovasc Res 2021;117:1645-61. [PMID: 33723575 DOI: 10.1093/cvr/cvab080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Negro F, Caravelli P, Morganti R, Casini M, Ruocco L, Tripodi A, De Caterina R. The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106994] [Reference Citation Analysis]
23 Bittman J, Thomson CJ, Lyall LA, Alexis SL, Lyall ET, Cannatella SL, Ebtia M, Freedman BK, Alizadeh-pasdar N, Ledrew JM, Orenstein Lyall TL. Effect of an Exercise and Nutrition Program on Quality of Life in Patient with Atrial Fibrillation: The Atrial Fibrillation Lifestyle Project (ALP). CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.004] [Reference Citation Analysis]
24 Oraii A, Healey JS, Benz AP, Pandey AK, Wong JA, Fonguh S, Wang J, Conen D, Gerstein H, Connolly SJ, McIntyre WF. Association of Eligibility for a Sodium-Glucose Co-transporter 2 Inhibitor and Cardiovascular Events in Patients with Atrial Fibrillation. Can J Cardiol 2022:S0828-282X(22)00288-4. [PMID: 35562018 DOI: 10.1016/j.cjca.2022.05.004] [Reference Citation Analysis]
25 Wu L, Li F, Chen J, Zhang J, Qian L, Wang R. Analysis of potential genetic biomarkers using machine learning methods and immune infiltration regulatory mechanisms underlying atrial fibrillation. BMC Med Genomics 2022;15. [DOI: 10.1186/s12920-022-01212-0] [Reference Citation Analysis]
26 Sandhu RK, Seiler A, Johnson CJ, Bunch TJ, Deering TF, Deneke T, Kirchhof P, Natale A, Piccini JP, Russo AM, Hills MT, Varosy PD, Araia A, Smith AM, Freeman J. Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers. Heart Rhythm 2022. [DOI: 10.1016/j.hrthm.2022.02.022] [Reference Citation Analysis]
27 Lévy S. Cardioversion of recent-onset atrial fibrillation using intravenous antiarrhythmics: A European perspective. J Cardiovasc Electrophysiol 2021;32:3259-69. [PMID: 34662471 DOI: 10.1111/jce.15264] [Reference Citation Analysis]
28 Murray K, Wahid M, Alagiakrishnan K, Senaratne J. Clinical electrophysiology of the aging heart. Expert Rev Cardiovasc Ther 2022;:1-17. [PMID: 35282746 DOI: 10.1080/14779072.2022.2045196] [Reference Citation Analysis]
29 Nair GM, Birnie DH, Wells GA, Nery PB, Redpath CJ, Sarrazin JF, Roux JF, Parkash R, Bernier M, Sterns LD, Novak P, Veenhuyzen G, Morillo CA, Singh SM, Sturmer M, Chauhan VS, Angaran P, Essebag V. Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale. Am Heart J 2022;248:1-12. [PMID: 35219715 DOI: 10.1016/j.ahj.2022.02.009] [Reference Citation Analysis]
30 Salmasi S, Adelakun A, Safari A, Kwan L, MacGillivray J, Andrade JG, Deyell MW, Kapanen A, Loewen P. Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study. CJC Open 2021;3:1347-56. [PMID: 34901803 DOI: 10.1016/j.cjco.2021.06.015] [Reference Citation Analysis]
31 Lau D, Sandhu RK, Andrade JG, Ezekowitz J, So H, Klarenbach S. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation. J Am Heart Assoc 2021;10:e019599. [PMID: 34238020 DOI: 10.1161/JAHA.120.019599] [Reference Citation Analysis]
32 Wang EHZ, Ye J, Turgeon R. Safety and Efficacy of Non-Vitamin K Oral Anticoagulant Use Early After Cardiac Surgery: A Systematic Review. Ann Pharmacother 2021;:10600280211006830. [PMID: 33813916 DOI: 10.1177/10600280211006830] [Reference Citation Analysis]
33 Halperin LF, Lee MK, Liew J, Lauck S, Kong D, Krahn AD, Deyell MW, Andrade JG, Hawkins NM, Chakrabarti S, John Yeung-lai-wah AF, Bennett MT, Cheung C, Levin A, Schwartz DI, Laksman ZW. Anticoagulation for Patients With Atrial Fibrillation and End-Stage Renal Disease on Dialysis: A National Survey. Canadian Journal of Cardiology 2021;37:924-8. [DOI: 10.1016/j.cjca.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 McIntyre WF, Wang MK, Conen D. Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation. Can J Cardiol 2021;37:938.e11. [PMID: 33137457 DOI: 10.1016/j.cjca.2020.10.011] [Reference Citation Analysis]
35 Feinberg JB, Olsen MH, Brandes A, Raymond L, Nielsen WB, Nielsen EE, Stensgaard-Hansen F, Dixen U, Pedersen OD, Gang UJO, Gluud C, Jakobsen JC. Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial. BMJ Open 2021;11:e044744. [PMID: 33789853 DOI: 10.1136/bmjopen-2020-044744] [Reference Citation Analysis]
36 Lévy S, Steinbeck G, Santini L, Nabauer M, Maceda DP, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol 2022. [PMID: 35419669 DOI: 10.1007/s10840-022-01195-z] [Reference Citation Analysis]
37 Carlin S, Eikelboom JW. Direct oral anticoagulant dose selection: Challenging cases. J Thromb Haemost 2021;19:2680-6. [PMID: 34558172 DOI: 10.1111/jth.15536] [Reference Citation Analysis]
38 Pacheco C, Mullen K, Coutinho T, Jaffer S, Parry M, Van Spall HG, Clavel M, Edwards JD, Sedlak T, Norris CM, Dhukai A, Grewal J, Mulvagh SL. THE CANADIAN WOMEN’S HEART HEALTH ALLIANCE ATLAS ON THE EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT OF CARDIOVASCULAR DISEASE IN WOMEN -- CHAPTER 5: SEX- AND GENDER-UNIQUE MANIFESTATIONS OF CARDIOVASCULAR DISEASE. CJC Open 2021. [DOI: 10.1016/j.cjco.2021.11.006] [Reference Citation Analysis]
39 Nattel S, Sager PT, Hüser J, Heijman J, Dobrev D. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovasc Res 2021;117:1616-31. [PMID: 33769493 DOI: 10.1093/cvr/cvab093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Dorian P, Ha ACT. Symptoms in Atrial Fibrillation: Patient and Physician Perspectives. JACC Clin Electrophysiol 2021;7:575-7. [PMID: 34016389 DOI: 10.1016/j.jacep.2020.11.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chung WH, Ajijola OA. Atrial fibrillation and stroke: The journey continues. Trends Cardiovasc Med 2021:S1050-1738(21)00168-7. [PMID: 34979177 DOI: 10.1016/j.tcm.2021.12.016] [Reference Citation Analysis]
42 López-Gálvez R, Marín F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J 2022;251:32-4. [PMID: 35537504 DOI: 10.1016/j.ahj.2022.05.007] [Reference Citation Analysis]
43 Murat S, Murat B, Gorenek B. Comments on efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus. Acta Cardiol 2021;76:1041. [PMID: 33635173 DOI: 10.1080/00015385.2021.1883905] [Reference Citation Analysis]
44 Verma S, Bhatt DL, Tseng EE. Time to Remove the Left Atrial Appendage at Surgery: LAAOS III in Perspective. Circulation 2021;144:1088-90. [PMID: 34606300 DOI: 10.1161/CIRCULATIONAHA.121.055825] [Reference Citation Analysis]
45 Lamarche MC, Alrajhi E, Wells PS. Direct oral anticoagulant use in special populations. Curr Opin Pulm Med 2021;27:311-8. [PMID: 34115699 DOI: 10.1097/MCP.0000000000000787] [Reference Citation Analysis]
46 Cho S, Yang PS, Kim D, You SC, Sung JH, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Joung B. Association of changes in cardiovascular health levels with incident cardiovascular events and mortality in patients with atrial fibrillation. Clin Res Cardiol 2022. [PMID: 35829750 DOI: 10.1007/s00392-022-02058-3] [Reference Citation Analysis]
47 Nattel S, Lip GYH, Filgueiras-Rama D, Dobrev D. Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation. Cardiovasc Res 2021;117:1609-11. [PMID: 34086918 DOI: 10.1093/cvr/cvab170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Abramson BL, Al-omran M, Anand SS, Albalawi Z, Coutinho T, de Mestral C, Dubois L, Gill HL, Greco E, Guzman R, Herman C, Hussain MA, Huckell VF, Jetty P, Kaplovitch E, Karlstedt E, Kayssi A, Lindsay T, Mancini GJ, Mcclure G, Mcmurtry MS, Mir H, Nagpal S, Nault P, Nguyen T, Petrasek P, Rannelli L, Roberts DJ, Roussin A, Saw J, Srivaratharajah K, Stone J, Szalay D, Wan D, Cox H, Verma S, Virani S. Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. Canadian Journal of Cardiology 2022;38:560-87. [DOI: 10.1016/j.cjca.2022.02.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 de Waard D, Fagan A, Minnaar C, Horne D. Prise en charge des patients après un pontage aortocoronarien: guide pour les professionnels en soins primaires. CMAJ 2021;193:E1107-13. [PMID: 34281973 DOI: 10.1503/cmaj.191108-f] [Reference Citation Analysis]
50 Shurrab M, Ryu R, Jackevicius CA. Off-Label Direct Oral Anticoagulant Dosing: Caution Advised. Circ Cardiovasc Qual Outcomes 2021;14:e008608. [PMID: 34932378 DOI: 10.1161/CIRCOUTCOMES.121.008608] [Reference Citation Analysis]
51 Daniel RC, Atzema CL, Cho DD, Davis PJ, Costello LL. Which recommendations are you using? A survey of emergency physician management of paroxysmal atrial fibrillation. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.01.005] [Reference Citation Analysis]
52 Siriez R, Yildiz H, Bouvy C, Haguet H, Maloteau V, Hardy M, Mullier F, Dogné J, Hainaut P, Douxfils J. The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12680] [Reference Citation Analysis]
53 Konieczyńska M, Bijak P, Malinowski KP, Undas A. Knowledge about atrial fibrillation and anticoagulation affects the risk of clinical outcomes. Thrombosis Research 2022;213:105-12. [DOI: 10.1016/j.thromres.2022.03.011] [Reference Citation Analysis]
54 Andrade JG, Macle L. Mortality Risk Associated with Atrial Fibrillation Ablation: No Harm No Foul. Can J Cardiol 2022:S0828-282X(22)00397-X. [PMID: 35777683 DOI: 10.1016/j.cjca.2022.06.017] [Reference Citation Analysis]
55 Lip GYH, Gue Y, Zhang J, Chao TF, Calkins H, Potpara T. Stroke Prevention in Atrial Fibrillation. Trends Cardiovasc Med 2021:S1050-1738(21)00113-4. [PMID: 34619337 DOI: 10.1016/j.tcm.2021.10.001] [Reference Citation Analysis]
56 Scheuermeyer FX, Targonsky E, Stiell I. Just the facts: Atrial fibrillation or flutter in patients who are candidates for rate control. CJEM 2021;23:437-40. [PMID: 33765287 DOI: 10.1007/s43678-021-00116-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Proietti M, Romiti GF, Vitolo M, Borgi M, Rocco AD, Farcomeni A, Miyazawa K, Healey JS, Lane DA, Boriani G, Basili S, Lip GYH. Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. Eur J Intern Med 2022:S0953-6205(22)00242-4. [PMID: 35817660 DOI: 10.1016/j.ejim.2022.06.023] [Reference Citation Analysis]
58 Andrade JG, Nattel S, Macle L. The Canadian Cardiovascular Society Atrial Fibrillation Guidelines Program: A Look Back Over the Last 10 Years and a Look Forward. Canadian Journal of Cardiology 2020;36:1839-42. [DOI: 10.1016/j.cjca.2020.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Eagle GE, Whitlock RP, Belley-côté EP. Reply to sex differences in the clinical outcomes after left atrial appendage: A systematic review and meta-analysis. Cardiovascular Revascularization Medicine 2022. [DOI: 10.1016/j.carrev.2022.03.024] [Reference Citation Analysis]
60 Orlandi M, Dover DC, Sandhu RK, Hawkins NM, Kaul P, Mcalister FA. The Introduction of Direct Oral Anticoagulants Has Not Resolved Treatment Gaps for Frail Patients With Nonvalvular Atrial Fibrillation. Canadian Journal of Cardiology 2022;38:77-84. [DOI: 10.1016/j.cjca.2021.09.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Thomas LE, Turakhia MP, Pencina MJ. Competing Risks, Treatment Switching, and Informative Censoring. JAMA Cardiol 2021;6:871-3. [PMID: 34009256 DOI: 10.1001/jamacardio.2021.1239] [Reference Citation Analysis]
62 Andrade JG, Wazni OM, Kuniss M, Hawkins NM, Deyell MW, Chierchia GB, Nissen S, Verma A, Wells GA, Turgeon RD. Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:914-30. [PMID: 34446164 DOI: 10.1016/j.jacc.2021.06.038] [Reference Citation Analysis]
63 Salmasi S, Safari A, Kapanen A, Adelakun A, Kwan L, MacGillivray J, Andrade JG, Deyell MW, Loewen P. Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study. Res Social Adm Pharm 2022:S1551-7411(22)00180-2. [PMID: 35753963 DOI: 10.1016/j.sapharm.2022.06.002] [Reference Citation Analysis]
64 Alipour P, Azizi Z, Norris CM, Raparelli V, McMurtry MS, Macle L, Andrade J, Pilote L. Representation of Females in Atrial Fibrillation Clinical Practice Guidelines. Can J Cardiol 2022:S0828-282X(22)00002-2. [PMID: 35007706 DOI: 10.1016/j.cjca.2021.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Simard T, Jung RG, Hibbert B, Holmes DR Jr, Alkhouli M. Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account. J Am Coll Cardiol 2021;78:e159. [PMID: 34736571 DOI: 10.1016/j.jacc.2021.09.007] [Reference Citation Analysis]
66 Andrade JG, Chierchia GB, Kuniss M, Wazni OM. New evidence: Cryoballoon ablation vs. antiarrhythmic drugs for first-line therapy of atrial fibrillation. Europace 2022;24:ii14-21. [PMID: 35661868 DOI: 10.1093/europace/euab246] [Reference Citation Analysis]
67 Barry AR, Babadagli HE, Boswell R, Chen JW, Dawson EL, Lopaschuk DG, McMillan CL, Nguyen BV, Omar MA, Pollmann DM, Zhou JS, Ackman ML. Review of the top 5 cardiology studies of 2019-20. Can Pharm J (Ott) 2021;154:388-93. [PMID: 34777649 DOI: 10.1177/17151635211029328] [Reference Citation Analysis]
68 Kim K, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Sung JH, Pak HN, Lee MH, Lip GYH, Joung B. Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study. Am Heart J 2021;242:123-31. [PMID: 34480879 DOI: 10.1016/j.ahj.2021.08.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 O'Neill DE, Forman DE. Cardiovascular care of older adults. BMJ 2021;374:n1593. [PMID: 34465575 DOI: 10.1136/bmj.n1593] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Leblanc K, Macgillivray J, Carroccia A, Macle L, Andrade JG. The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways. Can Pharm J 2022;155:107-18. [DOI: 10.1177/17151635211058160] [Reference Citation Analysis]
71 Cirasa A, La Greca C, Pecora D. Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines. Curr Heart Fail Rep 2021;18:153-62. [PMID: 33817773 DOI: 10.1007/s11897-021-00508-z] [Reference Citation Analysis]
72 de Waard D, Fagan A, Minnaar C, Horne D. Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners. CMAJ 2021;193:E689-94. [PMID: 33972222 DOI: 10.1503/cmaj.191108] [Reference Citation Analysis]
73 Michael F, Natt N, Shurrab M. Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis. CJC Open 2021;3:1169-81. [PMID: 34712941 DOI: 10.1016/j.cjco.2021.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Leelapatana P, Limpuangthip N. Association between oral health and atrial fibrillation: A systematic review. Heliyon 2022;8:e09161. [DOI: 10.1016/j.heliyon.2022.e09161] [Reference Citation Analysis]
75 Yan T, Zhu S, Zhu M, Wang C, Guo C. Integrative Identification of Hub Genes Associated With Immune Cells in Atrial Fibrillation Using Weighted Gene Correlation Network Analysis. Front Cardiovasc Med 2020;7:631775. [PMID: 33553270 DOI: 10.3389/fcvm.2020.631775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Imberti JF, Mei DA, Vitolo M, Bonini N, Proietti M, Potpara T, Lip GYH, Boriani G. Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med 2022:S0953-6205(22)00166-2. [PMID: 35525635 DOI: 10.1016/j.ejim.2022.04.023] [Reference Citation Analysis]
77 Sposato LA, Andrade J. Prolonged Cardiac Monitoring for Atrial Fibrillation Detection After Stroke: In Search of the Elusive Sweet Spot. Neurology 2022;98:781-3. [PMID: 35264425 DOI: 10.1212/WNL.0000000000200333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Hoff SJ. Evaluation and Interventional Management of Cardiac Dysrhythmias. Surgical Clinics of North America 2022. [DOI: 10.1016/j.suc.2022.01.003] [Reference Citation Analysis]
79 Govindapillai A, Cox JL, Thabane L, Doucette S, Xie F, Mackillop JH, Ciaccia A, Choudhri SH, Nemis-white JM, Hamilton LM, Parkash R. Rhythm control versus rate control in a contemporary ambulatory atrial fibrillation cohort: Post-hoc analysis of the IMPACT-AF Trial. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.03.001] [Reference Citation Analysis]
80 Stiell IG, Archambault PM, Morris J, Mercier E, Eagles D, Perry JJ, Scheuermeyer F, Clark G, Gosselin S, Vadeboncoeur A, Parkash R, de Wit K, Patey A, Thiruganasambandamoorthy V, Taljaard M; RAFF3 Study Investigators. RAFF-3 Trial: A Stepped-Wedge Cluster Randomized Trial to Improve Care of Acute Atrial Fibrillation and Flutter in the Emergency Department. Can J Cardiol 2021:S0828-282X(21)00351-2. [PMID: 34217808 DOI: 10.1016/j.cjca.2021.06.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Salmasi S, Högg T, Safari A, De Vera MA, Lynd LD, Koehoorn M, Barry AR, Andrade JG, Loewen P. The Random Effects Warfarin Days' Supply (REWarDS) Model: Development and Validation of a Novel Method for Estimating Exposure to Warfarin Using Administrative Data. Am J Epidemiol 2022;191:1116-24. [PMID: 35015808 DOI: 10.1093/aje/kwab295] [Reference Citation Analysis]
82 Lazarte J, Dron JS, McIntyre AD, Skanes AC, Gula LJ, Tang AS, Tadros R, Laksman ZW, Hegele RA, Roberts JD. Evaluating Polygenic Risk Scores in "Lone" Atrial Fibrillation. CJC Open 2021;3:751-7. [PMID: 34169254 DOI: 10.1016/j.cjco.2021.02.001] [Reference Citation Analysis]
83 Stiell IG, Targonsky E, Scheuermeyer F. Just the facts: atrial fibrillation or flutter in patients who are candidates for rhythm control. CJEM 2021;23:441-4. [PMID: 33825177 DOI: 10.1007/s43678-021-00120-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Stiell IG, Eagles D, Nemnom MJ, Brown E, Taljaard M, Archambault PM, Birnie D, Borgundvaag B, Clark G, Davis P, Godin D, Hohl C, Mathieu B, McRae AD, Mercier E, Morris J, Parkash R, Perry JJ, Rowe BH, Thiruganasambandamoorthy V, Scheuermeyer F, Sivilotti MLA, Vadeboncoeur A; RAFF Investigators. Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial Flutter. Can J Cardiol 2021:S0828-282X(21)00663-2. [PMID: 34474123 DOI: 10.1016/j.cjca.2021.08.018] [Reference Citation Analysis]
85 Chan N, Orchard J, Agbayani M, Boddington D, Chao T, Johar S, John B, Joung B, Krishinan S, Krittayaphong R, Kurokawa S, Lau C, Lim TW, Linh PT, Long VH, Naik A, Okumura Y, Sasano T, Yan B, Raharjo SB, Hanafy DA, Yuniadi Y, Nwe N, Awan ZA, Huang H, Freedman B. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening. Journal of Arrhythmia. [DOI: 10.1002/joa3.12669] [Reference Citation Analysis]
86 Gula LJ, Skanes AC. Insufficient Use of Anticoagulation for Frail Patients With Atrial Fibrillation: Still Stuck in the "Early Majority" Phase. Canadian Journal of Cardiology 2022;38:9-10. [DOI: 10.1016/j.cjca.2021.10.010] [Reference Citation Analysis]
87 Salmasi S, De Vera MA, Safari A, Lynd LD, Koehoorn M, Barry AR, Andrade JG, Deyell MW, Rush K, Zhao Y, Loewen P. Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation. J Am Coll Cardiol 2021;78:2395-404. [PMID: 34886959 DOI: 10.1016/j.jacc.2021.09.1370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Gladstone DJ, Lindsay MP, Douketis J, Smith EE, Dowlatshahi D, Wein T, Bourgoin A, Cox J, Falconer JB, Graham BR, Labrie M, McDonald L, Mandzia J, Ngui D, Pageau P, Rodgerson A, Semchuk W, Tebbutt T, Tuchak C, van Gaal S, Villaluna K, Foley N, Coutts S, Mountain A, Gubitz G, Udell JA, McGuff R, Poppe AY. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020. Can J Neurol Sci 2021;:1-23. [PMID: 34140063 DOI: 10.1017/cjn.2021.127] [Reference Citation Analysis]
89 Carnicelli AP, Owen R, Pocock SJ, Brieger DB, Yasuda S, Nicolau JC, Goodman SG, Cohen MG, Simon T, Westermann D, Hedman K, Andersson Sundell K, Granger CB. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open Heart 2021;8:e001726. [PMID: 34911791 DOI: 10.1136/openhrt-2021-001726] [Reference Citation Analysis]
90 Lee MY, Han S, Bang OY, On YK, Jang SW, Han S, Ryu J, Park YJ, Kang S, Suh HS, Kim YH. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea. Adv Ther 2022. [PMID: 35524839 DOI: 10.1007/s12325-022-02151-z] [Reference Citation Analysis]
91 Tavazzi L, Maggioni AP, Rapezzi C, Ferrari R. Heart failure and catheter ablation of atrial fibrillation: Navigating the difficult waters of heart failure phenotypes. Eur J Intern Med 2022:S0953-6205(22)00086-3. [PMID: 35241349 DOI: 10.1016/j.ejim.2022.02.021] [Reference Citation Analysis]